Prophylactic defibrillators in patients with severe chronic kidney disease.
Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Sheldon M
SM
Singh
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Xuesong
X
Wang
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Peter C
PC
Austin
Department of Medicine, University Health Network, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada5Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Rulan S
RS
Parekh
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada6Peter Munk Cardiac Center, University Health Network, Toronto, Ontario, Canada.
Douglas S
DS
Lee
D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D017147:Defibrillators, Implantable; D005260:Female; D006333:Heart Failure / Q000150:complications* / Q000628:therapy*; D006801:Humans; D053208:Kaplan-Meier Estimate; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009864:Ontario / Q000453:epidemiology